Back to Journals » Therapeutics and Clinical Risk Management » Pharmacological Treatments for Obesity
SJR OA
CiteScore
Impact Factor
Therapeutics and Clinical Risk Management
ISSN: 1178-203X
- View all (2615)
- Volume 22, 2026 (59)
- Volume 21, 2025 (162)
- Volume 20, 2024 (86)
- Volume 19, 2023 (91)
- Volume 18, 2022 (104)
- Volume 17, 2021 (134)
- Volume 16, 2020 (134)
- Volume 15, 2019 (154)
- Volume 14, 2018 (271)
- Volume 13, 2017 (188)
- Volume 12, 2016 (217)
- Volume 11, 2015 (210)
- Volume 10, 2014 (113)
- Volume 9, 2013 (57)
- Volume 8, 2012 (47)
- Volume 7, 2011 (59)
- Volume 6, 2010 (66)
- Volume 5, 2009 (102)
- Volume 4, 2008 (148)
- Volume 3, 2007 (126)
- Volume 2, 2006 (47)
- Volume 1, 2005 (40)
Journal Articles:
- Older and newer players in the therapeutics of Cardio-Kidney-Metabolic syndrome (1)
- Machine Learning in the Realm of Therapeutics and Clinical Risk Management (1)
- Lymphoproliferation at the crossroad between hematology and immunology: molecular and clinical implications (1)
- Anticholinergic Therapies for the Treatment of Asthma (7)
Pharmacological Treatments for Obesity
Obesity is a major public health threat, increasing the risk of chronic diseases and placing a significant burden on healthcare systems. Since their clinical introduction, pharmacotherapies have transformed patient care, offering benefits in weight reduction and improved metabolic health. Given the importance of pharmacological treatments in managing obesity, Therapeutics and Clinical Risk Management here collects original research articles, reviews, and perspectives exploring the clinical efficacy, safety, mechanisms of action, and real-world application of these transformative therapies.